New horizons for uncommon mutations in non-small cell lung cancer: BRAF, KRAS, RET, MET, NTRK, HER2-Reference-Cited by-同舟云学术

New horizons for uncommon mutations in non-small cell lung cancer: BRAF, KRAS, RET, MET, NTRK, HER2

Published:2022-04-24 Issue:4 Volume:13 Page:276-286
ISSN:2218-4333
Container-title:World Journal of Clinical Oncology
language:
Short-container-title:WJCO

Author:

Olmedo Maria Eugenia,Cervera Raquel,Cabezon-Gutierrez Luis,Lage Yolanda,Corral de la Fuente Elena,Gómez Rueda Ana,Mielgo-Rubio Xabier,Trujillo Juan Carlos,Couñago Felipe

Publisher

Baishideng Publishing Group Inc.

Subject

Oncology

Reference55 articles.

1. Osimertinib versus platinum–pemetrexed for patients with EGFR T790M advanced NSCLC and progression on a prior EGFR-tyrosine kinase inhibitor: AURA3 overall survival analysis

2. Crizotinib versus Chemotherapy in AdvancedALK-Positive Lung Cancer

3. Molecular Testing Guideline for the Selection of Patients With Lung Cancer for Treatment With Targeted Tyrosine Kinase Inhibitors: American Society of Clinical Oncology Endorsement of the College of American Pathologists/International Association for the Study of Lung Cancer/Association for Molecular Pathology Clinical Practice Guideline Update

4. Crizotinib in ROS1-rearranged advanced non-small-cell lung cancer (NSCLC): updated results, including overall survival, from PROFILE 1001

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. KIAA1429 Induces m6A Modification of LINC01106 to Enhance the Malignancy of Lung Adenocarcinoma Cells via the JAK/STAT3 Pathway;Critical Reviews in Immunology;2024

2. The new idea of cancer immunotherapy: the expression of PD-L1 may reveal the immunological mechanism of resistance of EGFR-TKIs;2023-12-06

3. Locally Advanced Lung Cancer;Hematology/Oncology Clinics of North America;2023-06

4. Targeting immune cell types of tumor microenvironment to overcome resistance to PD-1/PD-L1 blockade in lung cancer;Frontiers in Pharmacology;2023-02-15

5. Histopathological Aspects of the Prognostic Factors for Salivary Gland Cancers;Cancers;2023-02-15